Medical Technology Company Yao Ji Ke Closes ￥10M Seed Round

(VCBeat) Jan 13, 2021 -- Today Shenzhen Yao Ji Ke Technology Co., Ltd. ("Geeky Medical") announced the completion of a seed round financing of RMB10 million. Proceeds from this funding round will be used for R&D of the company’s SaaS system and market promotion.

Founded on February 14, 2019, Geeky Medical is a digital transformation service provider of pharmaceutical retail. It is committed to serving the middle and lower reaches of the pharmaceutical retail industry chain, building a terminal-oriented service platform, providing a one-stop solution of "medical care + drug + service", and providing consumers with better and safer drug purchase services.

After two years of development, Geeky Medical has successfully built three businesses, including online medical care, traditional medicine services, and digital marketing & big data services. Based on the self-developed Yaodaoyun Electronic Prescribing Platform, Yaokangfu Health Service Platform, Yaojike B2B Purchasing Platform of Chronic Disease, O2O medical e-commerce system solutions, etc., Geeky Medical has formed a closed-loop cycle of its business.

At present, Geeky Medical has reached cooperation and signed agreements with industry-related resources such as Chunyu Yisheng, Lianou Jiankang, Dakanghua Pharmaceutical, and Chuangmei Pharmaceutical.

By providing online medical services, O2O e-commerce solutions, drug purchasing, product marketing, digital tool solutions and other services for pharmacies, Geeky Medical improves the operating efficiency of pharmacies, reduces their operating costs, and helps them with digitalization. 

In 2020, Geeky Medical began to expand its business in Guangdong Province, serving more than pharmacies and reached strategic cooperation of sale channels with local leading pharmaceutical enterprises in 10 cities such as Guangzhou, Dongguan, Foshan, Huizhou, and Zhuhai.

Geeky Medical will further expand its market and develop chronic disease management services in 2021. At the same time, the company will also launch the national market investment project, trying to work with more practitioners in the big health industry through the combination of "SaaS system + chronic disease management service (pharmaceutical service)".